GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxart Inc (STU:NB11) » Definitions » Other Current Liabilities

Vaxart (STU:NB11) Other Current Liabilities : €5.94 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Vaxart Other Current Liabilities?

Vaxart's other current liabilities for the quarter that ended in Mar. 2024 was €5.94 Mil.

Vaxart's quarterly other current liabilities increased from Sep. 2023 (€6.08 Mil) to Dec. 2023 (€7.68 Mil) but then declined from Dec. 2023 (€7.68 Mil) to Mar. 2024 (€5.94 Mil).

Vaxart's annual other current liabilities declined from Dec. 2021 (€3.21 Mil) to Dec. 2022 (€3.03 Mil) but then increased from Dec. 2022 (€3.03 Mil) to Dec. 2023 (€7.68 Mil).


Vaxart Other Current Liabilities Historical Data

The historical data trend for Vaxart's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxart Other Current Liabilities Chart

Vaxart Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vaxart Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Vaxart Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Vaxart Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Vaxart's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaxart (STU:NB11) Business Description

Industry
Traded in Other Exchanges
Address
170 Harbor Way, Suite 300, South San Francisco, CA, USA, 94080
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Vaxart (STU:NB11) Headlines

No Headlines